This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Steffan Prowe: Innovator in Enzyme Technology
Introduction
Steffan Prowe is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of enzyme technology, particularly through his work on alkaline stable amylases. His innovative approach has led to advancements that have potential applications in various industrial sectors.
Latest Patents
Steffan Prowe holds a patent for an alkaline stable amylase derived from Thermoalcalibacter bogoriae. This invention relates to a novel enzyme composition that includes the amylase and outlines its use in several industrial applications. The patent showcases his expertise in biochemistry and enzyme engineering.
Career Highlights
Currently, Steffan Prowe is employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to further explore and develop innovative solutions in enzyme technology. His work has been instrumental in advancing the understanding and application of enzymes in various industries.
Collaborations
Steffan has collaborated with notable colleagues such as Carsten Sjo Slashedholm and Garabed Antranikian. These collaborations have enriched his research and contributed to the successful development of his patented technologies.
Conclusion
Steffan Prowe's contributions to enzyme technology through his patent and work at Novo Nordisk A/S highlight his role as an innovator in the field. His research continues to pave the way for new industrial applications of enzymes.